Meridian Bioscience Revenue Quarterly YoY Growth:
-0.37% for Dec. 31, 2012Meridian Bioscience Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -0.37% |
| Dec. 31, 2012 | 13.17% |
| Sept. 30, 2012 | 5.67% |
| June 30, 2012 | 5.22% |
| March 31, 2012 | 15.54% |
| Dec. 31, 2011 | 7.55% |
| Sept. 30, 2011 | 16.35% |
| June 30, 2011 | 18.30% |
| March 31, 2011 | 31.82% |
| Dec. 31, 2010 | -12.23% |
| Sept. 30, 2010 | -16.30% |
| June 30, 2010 | -11.46% |
| March 31, 2010 | -6.41% |
| Dec. 31, 2009 | 23.81% |
| Sept. 30, 2009 | 16.41% |
| June 30, 2009 | 15.64% |
| March 31, 2009 | -8.19% |
| Dec. 31, 2008 | 1.32% |
| Sept. 30, 2008 | 12.63% |
| June 30, 2008 | 11.10% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
VIVO Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Abaxis | 16.93% |
| Trinity Biotech | 4.05% |
| SurModics | 16.24% |
VIVO Revenue Quarterly YoY Growth Rankings
| Overall |
58th percentile 3129 of 7590 |
| Sector |
48th percentile 336 of 651 in Healthcare |
| Industry |
29th percentile 43 of 61 in Diagnostics & Research |
VIVO Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -16.30% | Sep 2010 |
| Maximum | 31.82% | Mar 2011 |
| Average | 6.98% |
